Evidence map›Paper›PMID 35340201›Full record

ArticleOxidative medicine and cellular longevity2022

Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways.

Ying Li, Yang Lv, Yu Zhu, Xiaodong Yang, Boya Lin, Mengqing Li, Yaqi Zhou, Zhibo Tan, Eun Ha Choi, Junjie Wang and 2 more

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. [Licochalcone A induces cell cycle arrest in human lung squamous carcinoma cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ying LiDepartment of Radiation Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen Peking University-Hong Kong University of Science & Technology Medical Center, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-1540-8397
Yang LvState Key Laboratory of Advanced Electromagnetic Engineering and Technology, Huazhong University of Science and Technology, Wuhan 430030, China.ORCID https://orcid.org/0000-0002-7179-4552
Yu ZhuDepartment of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-2144-0019
Xiaodong YangDepartment of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-7393-6489
Boya LinDepartment of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-4674-350X
Mengqing LiDepartment of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-0674-5623
Yaqi ZhouDepartment of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0003-3025-6931
Zhibo TanDepartment of Radiation Oncology, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-9673-1371
Eun Ha ChoiDepartment of Electrical and Biological Physics, Plasma Bioscience Research Center, Applied Plasma Medicine Center, Kwangwoon University, Seoul 01897, Republic of Korea.ORCID https://orcid.org/0000-0002-6926-6072
Junjie WangDepartment of Radiation Oncology, Peking University Third Hospital, Beijing 100083, China.ORCID https://orcid.org/0000-0002-4092-2232
Shubin WangDepartment of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID https://orcid.org/0000-0002-8641-8488
Yajie LiuDepartment of Radiation Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen Peking University-Hong Kong University of Science & Technology Medical Center, Shenzhen 518036, China.ORCID https://orcid.org/0000-0001-5077-6745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-temperature plasma, an engineered technology to generate various reactive species, is actively studied in cancer treatment in recent years, yet mainly by using a traditional 2D cell culture system. In this study, we explored the effect of the plasma-activated medium (PAM) on lung cancer cells

Indexed as

Lung NeoplasmsPhosphatidylinositol 3-KinasesAnimalsCell ProliferationHumansMiceProto-Oncogene Proteins c-aktTemperaturePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID35340201
PMCPMC8956395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.